Six NCI-designated cancer centers have agreed to pool data from their electronic medical record systems and cancer registries to accelerate discovery of targets and the development of biomarkers.
The National Cancer Institute Harold Varmus will leave on March 31 is leaner, cleaner, and more focused than it was on July 12, 2010, the day he became its 14th director.
A group of eight past chairs of the MD Anderson Cancer Center Faculty Senate have weighed into the controversy over leadership and morale at the Houston-based hospital.
The Faculty Senate of MD Anderson Cancer Center asked UT System officials and the Board of Regents to “provide guidance” to the administration of the Houston-based center “in establishing milestones and timelines to implement measures to improve the morale of the faculty and the general health of the Institution.”
NCI will implement President Barack Obama's directive to ramp up the initiative in precision medicine, even if Congress doesn't appropriate specific funds for this purpose, Institute Director Harold Varmus told members of the National Cancer Advisory Board Feb. 12.
In the next few weeks, FDA will announce its decision on Novartis's Zarxio, a granulocyte-colony stimulating factor biosimilar to Amgen's Neupogen.
Rising 19,341 feet above sea level, Mt. Kilimanjaro is the highest mountain in Africa and the tallest freestanding mountain in the world. It is a dormant but non-extinct volcano which last erupted some 150,000 years ago.
At first glance, it's hard to imagine anything as obscure as a policy by a private contracting firm that runs the Medicare program in the Carolinas, Virginia and West Virginia.
In May 2008, the Blue Devils of genomic medicine were facing a mortal threat.
Duke University would have avoided embarrassment, a misconduct investigation and a lawsuit, had its top administrators paid closer attention to a thoughtful report by a medical student who saw problems in the lab of the disgraced scientist Anil Potti.
